HCID 66914543, compound → HCID 66914516, compound

HRID 43130Notes

Reaction equation

HRID 43130 reaction equation
Br[C:2]1[CH:11]=[CH:10][C:9]([C:12]2[C:13]([CH3:19])=[N:14][CH:15]=[C:16]([CH3:18])[CH:17]=2)=[C:8]2[C:3]=1[N:4]=[CH:5][CH:6]=[N:7]2.[C:20]([Cu])#[N:21]>CN1C(=O)CCC1.C(Cl)Cl.C(N)CN>[CH3:19][C:13]1[C:12]([C:9]2[C:8]3[N:7]=[CH:6][CH:5]=[N:4][C:3]=3[C:2]([C:20]#[N:21])=[CH:11][CH:10]=2)=[CH:17][C:16]([CH3:18])=[CH:15][N:14]=1

Participants

6

Conditions

Temperature
160 °C

Procedure

A mixture of 5-bromo-8-(2,5-dimethyl-pyridin-3-yl)-quinoxaline (Step 99.4) (189 mg, 0.60 mmol) and CuCN (70 mg, 0.78 mmol, 1.3 equiv) in NMP (2 mL) was stirred for 6 h at 160° C., under an argon atmosphere. The reaction mixture was allowed to cool to rt, diluted with DCM/10% aqueous solution of ethylenediamine (25 mL), extracted with DCM. The organic phase was washed with H2O and brine, dried (Na2SO4), filtered and concentrated. The residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 94:5:1) to afford 150 mg of the title compound as a yellow solid. Title compound: ESI-MS: 261.2 [M+H]+; tR=1.92 min (System 1); TLC: Rf=0.68 (DCM/MeOH/NH3aq, 94:5:1).

Workup

  1. temperatureto cool to rt
  2. extractionextracted with DCM
  3. washThe organic phase was washed with H2O and brine
  4. dry with materialdried (Na2SO4)
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 94:5:1)

Sources & evidence

ORD record
ord-69b3ca1f39744c84a26aafc04316217a
Source dataset
uspto-grants-2013_09
Patent number
US08536175B2

Reaction notes

Loading…